Morgan Stanley analyst James Faucette lowered the firm’s price target on Endava (DAVA) to $4 from $8 and keeps an Equal Weight rating on the shares after a broad based fiscal Q3 miss and downward FY26 outlook revision. The firm awaits improvements in broader budgets before turning constructive on potential AI-related tailwinds, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava downgraded to Underweight from Neutral at JPMorgan
- Endava Earnings Call: AI Momentum Meets Profit Squeeze
- Maggie Nolan Maintains Hold on Endava as Weaker Results and Outlook Offset Rapid AI-Driven Growth
- Endava Swings to Heavy Q3 Loss on Goodwill Hit as It Accelerates AI and Payments Pivot
- Endava sees Q4 adjusted EPS GBP 0.09-GBP 0.13